1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Hui Zhuang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students HBV vaccine (Engerix-B, recombinant hepatitis B surface antigen, 20µg/mL/vial, GlaxoSmithKline, Belgium) - Hepatitis B, Immune Response | Phase 4 | Completed | Hui Zhuang | 2040 | 2009-09-01 | 2013-05-24 |
Hepatitis B (1)
Engerix-B (1) · halofantrine (1)
China (1)